British American Tobacco p.l.c. is a London, United Kingdom-headquartered global tobacco and nicotine products company (NYSE: BTI) with a portfolio spanning combustibles (cigarettes, fine cut tobacco), new categories (Vapour, Heated Products, Modern Oral), and traditional oral (snus, moist snuff). For H1 2026 (six months ended June 30, 2026), reported revenue of £12.235 billion was up 1.4% (2.9% constant currency), driven by U.S. growth (+8.5% CC), AME resilience (+0.9% CC), and APMEA decline (-6.3% CC). Combustibles revenue up 1.3% (5.0% CC) despite 5.2% volume decline (price/mix + excise duty drawback offset). New Categories revenue up 18.0% (contribution margin +3.3 ppts to 13.8%), with Modern Oral +65.9% (Velo Plus U.S. +209%), Vapour double-digit U.S. growth, Heated Products mixed. Adjusted profit from operations down 16.5% at constant currency (reported operating margin down 7.1 ppts to 34.9%, partly due to prior-year Canadian settlement credit). Adjusted diluted EPS of 167.7p (+5.9% CC, +7.9% CC ex-Canada). Net cash from operations £3,402M (+47.3%), free cash flow pre-dividend £2,285M (+85.2%), cash conversion 79.7% (+34.1 ppts). Adjusted net debt £31,969M (+7.5%), leverage targeting 2.0-2.5x by year-end. Dividend growth commitment in sterling, £1.3B buyback program. Full-year guidance confirmed: global cigarette volume down ~3%, revenue 3-5% growth (mid-teens New Categories), adjusted profit from operations 4-6% growth (H2 weighted).
The investment thesis rests on three variables. The New Categories scaling and profitability inflection is the load-bearing growth variable, with New Categories revenue at 19.8% of Group revenue (+1.6 ppts), contribution margin at 13.8% (+3.3 ppts), Modern Oral now largest new category (39.2% volume share in top markets, +8.4 ppts vs FY25), Velo Plus U.S. +209%, and the strategic intent is to continue the portfolio mix shift toward higher-margin non-combustible products. The U.S. combustibles resilience and the market share trajectory is the load-bearing core variable, with U.S. revenue +8.5% CC, Vapour value share 55.9% (+4.1 ppts), Modern Oral volume share 29.8% (+11.6 ppts), combustibles volume +14.9% (inventory and share gains), and the strategic intent is to defend the U.S. profit pool while managing the secular volume decline. The deleveraging and the Canadian settlement resolution is the load-bearing financial variable, with adjusted net debt £31.97B targeting 2.0-2.5x leverage by year-end, £1.3B buyback, Canadian settlement provision (85% adjusted in 2026 vs 100% in 2025) creating EPS bridge, and the strategic intent is to achieve the leverage corridor while maintaining shareholder returns.